LEVERAGE LONG - SARTORIUS STEDIM BIO Share Price

Certificat

51Y8S

DE000SQ3LGS9

Market Closed - Euronext Paris 17:30:00 13/05/2024 BST
0.0136 EUR -8.72% Intraday chart for LEVERAGE LONG - SARTORIUS STEDIM BIO
Current month-6.21%
1 month-90.62%
Date Price Change Volume
13/05/24 0.0136 -8.72% 57
10/05/24 0.0149 -2.61% 74
09/05/24 0.0153 +3.38% 55
08/05/24 0.0148 -5.73% 76
07/05/24 0.0157 +3.97% 63

Real-time Euronext Paris

Last update May 13, 2024 at 05:30 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying SARTORIUS STEDIM BIOTECH
IssuerLogo Issuer Société Générale Société Générale
51Y8S
ISINDE000SQ3LGS9
Date issued 31/10/2022
Maturity Unlimited
Parity 1 : 1
Emission price 50.66
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 81.02
Lowest since issue 0.0111

Company Profile

Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany.
Sector
-
More about the company

Ratings for Sartorius Stedim Biotech

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Sartorius Stedim Biotech

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
203.6 EUR
Average target price
251.3 EUR
Spread / Average Target
+23.44%
Consensus
  1. Stock Market
  2. Certificates
  3. 51Y8S Certificat